Skip to main content
  1. Research projects/

B04: Investigating psychological and neural correlates of intimate partner violence

Focus on the neural correlates of characterizing cognitive control deficits during conflict situations. The project will investigate patients with varying levels of cognitive control along with their close partners (sibling or intimate partner) to identify the dynamics of self-regulation and co-regulation in provoked conflict situations in patients with control deficits. To identify the precursors and dynamics of conflict escalation, the project will apply measures of behavioral reactions, skin conductance, simulated or real conflict, fMRI and fMRI-hyperscanning techniques and physiological measures. Neuroimaging data will also be combined with information on stress, control and conflicts in real-life via EMA.

Contributors


Andreas Meyer-Lindenberg

Andreas Meyer-Lindenberg is a distinguished psychiatrist and neuroscientist based in Germany, renowned for his groundbreaking research on the neurobiological underpinnings of psychiatric disorders. He serves as the Director of the Central Institute of Mental Health (ZI) in Mannheim and is a professor at the University of Heidelberg. Meyer-Lindenberg’s work focuses on understanding how genetic and environmental factors influence brain function and contribute to mental illnesses such as schizophrenia and depression. His contributions have significantly advanced the field of psychiatric neuroscience, providing deeper insights into the mechanisms of mental health disorders and informing the development of more effective treatments.

Publications


A cognitive neuroscience approach to understanding aggression and its treatment

While anyone can behave aggressively, some people are more prone to aggression than others. We present a neuro-cognitive model and consider several inter-individual differences that confer risk for aggression. Forms of atypical cognitive function include a hyperreactive acute threat response, poor emotion regulation, and mechanisms involved in choosing when to aggress. We show dysfunction in the neural systems mediating these functions may account for aggression in people high in psychopathy/callous unemotional traits, irritability/anger, hostility, impulsivity, and low in frustration tolerance. We then review promising interventions including psychological therapies and pharmaceuticals that might influence the neuro-cognitive underpinnings of these constructs. Although there is no overwhelming “one size fits all” approach to treating aggression, identifying the neural mechanisms implicated in these traits may improve individualized treatments.

A mechanism-based group psychotherapy approach to aggressive behavior (MAAP) in borderline personality disorder: a multicenter randomized controlled clinical trial

High levels of trait anger and aggressive behavior are common and problematic phenomena in patients with borderline personality disorder (BPD). In BPD, patterns of reactive aggression often lead to functional impairment affecting important areas of life. Despite the high burden on individuals and their social environment, there are no specific, cost-effective treatments to reduce aggression in BPD. In previous studies, we and others have been able to infer specific biobehavioral mechanisms underlying patterns of reactive aggression in BPD that can be used as potential treatment targets. To address this, we developed a mechanism-based anti-aggression psychotherapy (MAAP) for the group setting that specifically targets the biobehavioral mechanisms underlying outward-directed aggression in BPD. A previously conducted proof-of-concept study had suggested beneficial effects for this neglected group of patients. In this multicenter, confirmatory, randomized-controlled-clinical-trial, MAAP, which consists of multifaceted, evidence-based treatment elements adapted from other sophisticated treatment programs such as Dialectical Behavior Therapy and Mentalization-Based Treatment, is tested for efficacy against a non-specific supportive psychotherapy (NSSP) program focusing on non-specific general factors of psychotherapy at seven different sites in Germany. Both treatment arms, based on one individual and 13 group therapeutic sessions (1.5 h per session, twice a week), are delivered over a period of 7–10 weeks. A total of N = 186 patients will be recruited, half of whom will be cluster-randomized to MAAP. Outcomes are assessed at baseline, immediately, and 4, 12, 20, and 24 weeks post-treatment using ecological momentary assessment, clinical interviews, questionnaires, and online tasks. If proven superior, MAAP can be incorporated into standard psychiatric care, filling a critical gap in the current therapeutic landscape by offering a structured, cost-effective, and evidence-based treatment that directly targets the biobehavioral mechanisms underlying reactive aggression in BPD. By potentially improving clinical outcomes and reducing the burden of reactive aggression in BPD, MAAP could be beneficial for both individuals and their social environments. The study’s large, multicenter design enhances the generalizability of the results, making them more relevant for broader clinical applications.

Identifying P100 and N170 as electrophysiological markers for conscious and unconscious processing of emotional facial expressions

Introduction: Everyday life requires correct processing of emotions constantly, partly occurring unconsciously. This study aims to clarify the effect of emotion perception on different event-related potentials (ERP; P100, N170). The P100 and N170 are tested for their suitability as electrophysiological markers in unconscious processing.

Methods: Using a modified backward masking paradigm, 52 healthy participants evaluated emotional facial expressions (happy, sad, or neutral) during EEG recording. While varying primer presentation time (16.7 ms for unconscious; 150 ms for conscious perception), either congruent or incongruent primer / target emotions were displayed.